As shown in Figure 1D, E2F signature was significantly enriched in low SOSTDC1 expression group, in comparison with high expression group, indicating preferential E2F activation in thyroid cancer specimens with low SOSTDC1 expression. Here, SOSTDC1 is linked to thyroid gland carcinoma.